PR Newswire - Caliway Makes First ECO 2026 Oral Presentation on ...
CBL-514, when combined separately with two leading GLP-1R-based weight-loss therapies, semaglutide and tirzepatide, demonstrated enhanced weight loss, attenuated post-discontinuation weight reg...
Read More

ภาษาไทย
English